Food allergy and features of nutritional status as a manifestation of epithelial barrier dysfunction in children with congenital ichthyosis
https://doi.org/10.33667/2078-5631-2026-9-82-88
Abstract
Congenital ichthyosis is a group of rare genetic disorders characterized by impaired keratinization and skin barrier dysfunction. The common pathogenetic link for various forms of ichthyosis is structural damage to the epidermis, leading to increased transepidermal water loss and reduced protective function, which creates conditions for transcutaneous sensitization to food allergens. This mechanism is particularly well described in Netherton syndrome, associated with a mutation in the SPINK5 gene, and vulgar ichthyosis, associated with mutations in the filaggrin gene. However, in other forms of congenital ichthyosis, the characteristics of food sensitization and manifestations of food allergy have not been studied. The penetration of food allergens through the damaged skin barrier triggers a cascade of immune reactions that contribute to the activation of the Th2 immune response and the production of specific IgE, often leading to food sensitization and food allergy. The development of food allergies in the context of congenital ichthyosis exacerbates the course of the underlying disease and contributes to the formation of nutritional status disorders and growth retardation due to both restrictive diets without adequate nutritional support and a deficiency of nutrients and trace elements. This review focuses on the role of epidermal barrier dysfunction as a key link in the development of comorbid food allergies in patients with congenital ichthyosis and emphasizes the need for an interdisciplinary approach for this category of patients.
About the Author
D. I. MustafaevaRussian Federation
Mustafaeva Dinara Ilgar kyzy, 2nd year graduate student, pediatricianNational Medical Research Center for Children’s Healt»
Moscow
References
1. Murashkin N. N., Avetisyan K. O., Ivanov R. A., Makarova S. G. Congenital Ichthyosis: Clinical and Genetic Characteristics of the Disease. Current Pediatrics. 2022; 21 (5): 362–377. (In Russ.). https://doi.org/10.15690/vsp.v21i5.2459
2. Vahlquist A, Törmä H. Ichthyosis: A Road Model for Skin Research. Acta Derm Venereol. 2020; 100 (7): adv00097. https://doi.org/10.2340/00015555-34333
3. Mazereeuw-Hautier J, Vahlquist A, Traupe H. et al. Management of congenital ichthyoses: European guidelines of care, part one. Br.J. Dermatol. 2019; 180 (2): 272–281. https://doi.org/10.1111/ bjd.17203
4. Oji V, Tadini G, Akiyama M. et al. Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sorèze 2009. J. Am. Acad Dermatol. 2010; 63 (4): 607–641. https://doi.org/10.1016/j.jaad.2009.11.020
5. Dabas G, Mahajan R, De D. et al. Managing syndromic congenital ichthyosis at a tertiary care institute-Genotype-pheno type correlations, and novel treatments. Dermatol Ther. 2020; 33 (6): e13816. https://doi.org/10.1111/dth.13816
6. Sun Q, Burgren N.M, Cheraghlou S, Paller A.S, Larralde M, Bercovitch L, Levinsohn J. et al. The Genomic and Phenotypic Landscape of Ichthyosis: An Analysis of 1000 Kindreds. JAMA Dermatol. 2022 Jan 1; 158 (1): 16–25. DOI: 10.1001/jamadermatol.2021.4242
7. Richard G. Autosomal Recessive Congenital Ichthyosis. In: GeneReviews [Internet]. Adam MP, Mirzaa GM, Pagon RA. et al, eds. Seattle (WA): University of Washington, Seattle. 1993–2022. Available online: https://www.ncbi.nlm.nih.gov/books/NBK1420. Accessed on October 27, 2022.
8. Mohamad J, Samuelov L, Malchin N. et al. Molecular epidemiology of non-syndromic autosomal recessive congenital ichthyosis in a Middle-Eastern population. Exp Dermatol. 2021; 30 (9): 1290–1297. https://doi.org/10.1111/exd.14345
9. Fischer J, Bourrat E. Genetics of Inherited Ichthyoses and Related Diseases. Acta Derm Venereol. 2020; 100 (7): adv00096. https://doi.org/10.2340/00015555-3432
10. Takeichi T, Akiyama M. Inherited ichthyosis: Non-syndromic forms. J. Dermatol. 2016; 43 (3): 242–251. https://doi.org/10.1111/1346-8138.13243
11. Gutiérrez-Cerrajero C, González-Sarmiento R, Hernández-Martín Á. [Translated article] ICHTHYOSIS: Clinical and Molecular Update. Part 2: Syndromic Ichthyosis. Diagnostic and Therapeutic Approach of Ichthyosis. Actas Dermosifiliogr. 2025 May; 116 (5): T497–T510. English, Spanish. DOI: 10.1016/j.ad.2025.03.013. Epub 2025 Mar 11.
12. Yoneda K. Inherited ichthyosis: Syndromic forms. J. Dermatol. 2016 Mar; 43 (3): 252–63. DOI: 10.1111/1346-8138.13284. PMID: 26945533.
13. Gutiérrez-Cerrajero, C., Sprecher, E., Paller, A.S. et al. Ichthyosis. Nat Rev Dis Primers. 2023; 9 (2). https://doi.org/10.1038/s41572-022-00412-3
14. Ishitsuka Y, Roop DR. The Epidermis: Redox Governor of Health and Diseases. Antioxidants (Basel). 2021 Dec 26; 11 (1): 47. DOI: 10.3390/antiox11010047
15. Lima Cunha D, Oram A, Gruber R, Plank R, Lingenhel A, Gupta MK. et al. hiPSC-Derived Epidermal Keratinocytes from Ichthyosis Patients Show Altered Expression of Cornification Markers. Int J. Mol Sci. 2021 Feb 11; 22 (4): 1785. DOI: 10.3390/ijms22041785
16. Paller AS, Renert Yuval Y, Suprun M, Esaki H, Oliva M, Huynh TN. et al. An IL-17 dominant immune profile is shared across the major orphan forms of ichthyosis. J. Allergy Clin Immunol. 2017; 139 (1): 152–65. DOI: 10.1016/j.jaci.2016.07.019
17. Hassani B, Isaian A, Shariat M, Mollanoori H, Sotoudeh S, Babaei V, Ziaali A, Teimourian S. Filaggrin gene polymorphisms in Iranian ichthyosis vulgaris and atopic dermatitis patients. Int J. Dermatol. 2018 Dec; 57 (12): 1485–1491. DOI: 10.1111/ijd.14213. Epub 2018 Sep 23. PMID: 30246302.
18. Stuvel K, Heeringa J.J, Dalm VASH. et al. Comel-Netherton syndrome: A local skin barrier defect in the absence of an underlying systemic immunodeficiency. Allergy. 2020 Jul; 75 (7): 1710–1720. DOI: 10.1111/all.14197
19. Scala E, Condorelli A.G, Scala A, Caprini E, Didona B, Paganelli R. et al. IgE Sensitization Profile in Patients with Netherton Syndrome. Int Arch Allergy Immunol. 2022; 183 (12): 1291–1296. DOI: 10.1159/000526409
20. Barbati F, Giovannini M, Oranges T. et al. Netherton Syndrome in Children: Management and Future Perspective. Front Pediatr. 2021; 9: 645259. https://doi.org/10.3389/fped.2021.645259
21. Mocarska M, Muciek A, Dolinkiewicz J, Maryńczak A.M, Nitschke N, Strakowska K. et al. Netherton Syndrome: A Comprehensive Literature Review of Pathogenesis, Clinical Manifestations, and Therapeutic Strategies. J. Mother Child. 2025 Sep 2; 29 (1): 106–113. DOI: 10.34763/jmotherandchild.20252901.d-25-00014
22. Wei-Li Di, John Harper. Netherton Syndrome. Harper’s Textbook of Pediatric Dermatology, Fourth Edition. 2019. https://doi.org/10.1002/9781119142812.ch132
23. Brough HA, Nadeau KC, Sindher SB, Alkotob SS, Chan S, Bahnson HT, Leung DYM, Lack G. Epicutaneous sensitization in the development of food allergy: What is the evidence and how can this be prevented? Allergy. 2020 Sep; 75 (9): 2185–2205. DOI: 10.1111/all.14304. Epub 2020 May 18. PMID: 32249942; PMCID: PMC7494573.
24. Sampson H.A., O’Mahony L., Burks A.W., Plaut M., Lack G., Akdis C.A. Mechanisms of food allergy. J. Allergy Clin. Immunol. 2018; 141: 11–19.
25. Kawasaki A, Ito N, Murai H, Yasutomi M, Naiki H, Ohshima Y. Skin inflammation exacerbates food allergy symptoms in epicutaneously sensitized mice. Allergy. 2018; 73: 1313–1321.
26. Barni S, Liccioli G, Sarti L, Giovannini M, Novembre E, Mori F. Immunoglobulin E (IgE)-Mediated Food Allergy in Children: Epidemiology, Pathogenesis, Diagnosis, Prevention, and Management. Medicina (Kaunas). 2020 Mar 4; 56 (3): 111. DOI: 10.3390/medicina56030111. PMID: 32143431; PMCID: PMC7142605.
27. Muraro A, Werfel T, Hoffmann-Sommergruber K. et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy. 2014; 69 (8): 1008–1025. DOI: 10.1111/all.12429
28. Food Allergies in Children and Adolescents: [Monograph] / S.G. Makarova, I.I. Balabolkin, A.P. Fisenko. Moscow: FSAI «National Medical Research Center of Children’s Health» of the Ministry of Health of Russia, 2021. 288 p. (Informational Materials).
29. Jutel M, Agache I, Zemelka-Wiacek M. et al. Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper. Allergy. 2023; 78: 2851–2874. DOI: 10.1111/all.15889
30. Balan S, Saxena M, Bhardwaj N. Dendritic cell subsets and locations. Int Rev Cell Mol Biol. 2019; 348: 1–68. DOI: 10.1016/bs.ircmb.2019.07.004
31. Gauvreau GM, Bergeron C, Boulet LP. et al. Sounding the alarmins-the role of alarmin cytokines in asthma. Allergy. 2023; 78 (2): 402–417 DOI: 10.1111/all.15609
32. Varricchi G, Bencivenga L, Poto R, Pecoraro A, Shamji MH, Rengo G. The emerging role of T follicular helper (TFH) cells in aging: influence on the immune frailty. Ageing Res Rev. 2020; 61: 101071. DOI: 10.1016/j.arr.2020.101071
33. Morita H, Kubo T, Rückert B. et al. Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid. J. Allergy Clin Immunol. 2019; 143 (6): 2190–2201.e9. DOI: 10.1016/j.jaci.2018.12.1018
34. Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J. Allergy Clin Immunol. 2010; 125(2 Suppl 2): S73–S80. DOI: 10.1016/j.jaci.2009.11.017
35. Valente M, Dölen Y, van Dinther E. et al. Cross-talk between iNKT cells and CD8 T cells in the spleen requires the IL-4/CCL17 axis for the generation of short-lived effector cells. Proc Natl Acad Sci USA. 2019; 116 (51): 25816–25827. DOI: 10.1073/pnas.1913491116
36. Eguiluz-Gracia I, Layhadi JA, Rondon C, Shamji MH. Mucosal IgE immune responses in respiratory diseases. A-Curr Opin Pharmacol. 2019; 46: 100–107. DOI: 10.1016/j.coph.2019.05.009
37. Gigon L, Fettrelet T, Yousefi S, Simon D, Simon HU. Eosinophils from a to Z. Allergy. 2023; 78 (7): 1810–1846. DOI: 10.1111/all.15751
38. Sugita K, Steer CA, Martinez-Gonzalez I. et al. Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients. J. Allergy Clin Immunol. 2018; 141 (1): 300–310.e11. DOI: 10.1016/j.jaci.2017.02.038
39. Akdis CA. Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? Nat Rev Immunol. 2021 Nov; 21 (11): 739–751. DOI: 10.1038/s41577-021-00538-7
40. Nakamura M, Kamiya K, Furuhata A, Ikeda K, Niyonsaba F. S100A7 Co-localization and up-regulation of Filaggrin in human Sinonasal epithelial cells. Curr Med Sci. 2021; 41 (5): 863–868. DOI: 10.1007/s11596-021-2431-1
41. Saito K, Orimo K, Kubo T. et al. Laundry detergents and surfactants induced eosinophilic airway inflammation by increasing IL-33 expression and activating ILC2s. Allergy. 2023; 78: 1878–1892.DOI: 10.1111/all.15762
42. Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E. Dysbiosis and the immune system. Nat Rev Immunol. 2017; 17 (4): 219–232. DOI: 10.1038/nri.2017.7
43. Fölster-Holst R, Naß C, Dähnhardt-Pfeiffer S, Freitag-Wolf S. Analysis of the structure and function of the epidermal barrier in patients with ichthyoses-clinical and electron microscopical investigations. J. Eur. Acad Dermatol Venereol. 2022 May; 36 (5): 726–738. DOI: 10.1111/jdv.17914
44. Mazereeuw-Hautier J., Dreyfus I., Barbarot S. et al. Ichthyosis and allergic sensitization. The British Journal of Dermatology, 2017.
45. Kim Y, Lim K.M. Skin barrier dysfunction and filaggrin. Arch Pharm Res. 2021 Jan; 44 (1): 36–48. DOI: 10.1007/s12272-021-01305-x
46. Brown SJ, Asai Y, Cordell HJ. et al. Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy. J. Allergy Clin Immunol. 2011; 127 (3): 661–667. DOI: 10.1016/j.jaci.2011.01.03
47. Gutiérrez-Cerrajero, C., Sprecher, E., Paller, A.S. et al. Ichthyosis. Nat Rev Dis Primers 9, 2 (2023). https://doi.org/10.1038/s41572-022-00412-3
48. Lefevre-Utile A, Braun C, Haftek M, Aubin F. Five functional aspects of the epidermal barrier. Int J. Mol Sci. 2021; 22: 11676.
49. Fluhr JW, Moore DJ, Lane ME, Lachmann N, Rawlings AV. Epidermal barrier function in dry, flaky and sensitive skin: A narrative review. J. Eur. Acad Dermatol Venereol. 2024; 38: 812–820. https://doi.org/10.1111/jdv.19745
50. Suzuki M, Ohno Y, Kihara A. Whole picture of human stratum corneum ceramides, including the chainlength diversity of long-chain bases. J. Lipid Res. 2022; 63: 100235.
51. Ohnemus U, Kohrmeyer K, Houdek P. et al. Regulation of epidermal tight junctions (TJ) during infection with exfoliative toxin-negative Staphylococcus strains. J Invest Dermatol 2007: in press.
52. Egawa G, Kabashima K. Barrier dysfunction in the skin allergy. Allergol Int. 2018; 67 (1): 3–11. DOI: 10.1016/j.alit.2017.10.002
53. Baroni A, Buommino E, De Gregorio V, Ruocco E, Ruocco V, Wolf R. Structure and function of the epidermis related to barrier properties. Clin Dermatol. 2012 May-Jun; 30 (3): 257–62. DOI: 10.1016/j.clindermatol.2011.08.007. PMID: 22507037.
54. Egawa G. Pathomechanism of ‘skin-originated’ allergic diseases. Immunological Medicine. 2018; 41 (4): 170–176. https://doi.org/10.1080/25785826.2018.1540257
55. Tham KC, Lefferdink R, Duan K, Lim SS, Wong XFCC, Ibler E, Wu B, Abu-Zayed H, Rangel SM, Del Duca E, Chowdhury M, Chima M, Kim HJ, Lee B, Guttman-Yassky E, Paller AS, Common JEA. Distinct skin microbiome community structures in congenital ichthyosis. Br.J. Dermatol. 2022 Oct; 187 (4): 557–570. DOI: 10.1111/bjd.21687. Epub 2022 Jul 4. PMID: 35633118; PMCID: PMC10234690.
56. Brough H.A., Lanser B. J., Sindher S. B., Teng J.M.C., Leung D. Y.M., Venter C., Chan S. M., Santos A. F., Bahnson H.T., Guttman-Yassky E. et al. Early intervention and prevention of allergic diseases. Allergy. 2022; 77: 416–441.
57. Dębińska A, Sozańska B. Epicutaneous Sensitization and Food Allergy: Preventive Strategies Targeting Skin Barrier Repair-Facts and Challenges. Nutrients. 2023 Feb 21; 15 (5): 1070. DOI: 10.3390/nu15051070. PMID: 36904070; PMCID: PMC10005101.
58. Leung D.Y.M., Berdyshev E., Goleva E. Cutaneous barrier dysfunction in allergic diseases. J. Allergy Clin. Immunol. 2020; 145: 1485–1497.
59. Zhu TH, Zhu TR, Tran KA, Sivamani RK, Shi VY. Epithelial barrier dysfunctions in atopic dermatitis: a skin-gutlung model linking microbiome alteration and immune dysregulation. Br.J. Dermatol. 2018; 179: 570–581.
60. van Splunter M, Liu L, van Neerven RJJ, Wichers HJ, Hettinga KA, de Jong NW. Mechanisms Underlying the Skin-Gut Cross Talk in the Development of IgE-Mediated Food Allergy. Nutrients. 2020 Dec 15; 12 (12): 3830. DOI: 10.3390/nu12123830
61. Sampson H.A, O’Mahony L, Burks A.W, Plaut M, Lack G, Akdis C.A. Mechanisms of food allergy. J. Allergy Clin Immunol. 2018 Jan; 141 (1): 11–19. DOI: 10.1016/j.jaci.2017.11.005.
62. Strid J, Hourihane J, Kimber I, Callard R, Strobel S. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur. J. Immunol 2004; 34: 2100–2109.
63. Novik G.A., Zhdanova M.V., Demidova A.S. Epicutaneous sensitization. what do we know? Bulletin of Siberian Medicine. 2021; 20 (4): 180–192. https://doi.org/10.20538/1682-0363-2021-4-180-192
64. Leyva-Castillo J.M., McGurk A., Geha M.D.R. Allergic skin inflammation and S. aureus skin colonization are mutually re inforcing. Clin. Immunol. 2020; 218: 108511. DOI: 10.1016/j.clim.2020.108511
65. Diaz LZ, Browning JC, Smidt AC, Rizzo WB, Levy ML. Complications of ichthyosis beyond the skin. Dermatol Ther. 2013 Jan-Feb; 26 (1): 39–45. DOI: 10.1111/j.1529-8019.2012.01517.x. PMID: 23384019.
66. Yang L, Xia JN. Beyond the Skin: Exploring the Gut-Skin Axis and Metabolic Pathways in Atopic Dermatitis Pathogenesis. Int J. Gen Med. 2025 Oct 8; 18: 6123–6136. DOI: 10.2147/IJGM.S550152. PMID: 41084738; PMCID: PMC12515402.
67. Tetarbe S, Jain S, Shah I. Hereditary Ichthyosis With Gastrointestinal Manifestations: A Case Report. JPGN Rep. 2023 Oct 9; 4 (4): e370. DOI: 10.1097/PG9.0000000000000370. PMID: 38034450; PMCID: PMC10684232.
68. Paluel-Marmont C, Bellon N, Barbet P. et al. Eosinophilic esophagitis and colonic mucosal eosinophilia in Netherton syndrome. J. Allergy Clin Immunol. 2017; 139 (6): 2003–2005.e1.
69. Fry L, McMinn RMH, Shuster S. The small intestine in skin diseases. Archives of Dermatology. 1966; 93: 647–653.
70. Ali IA, Foolad N, Sivamani RK. Considering the gut-skin axis for dermatological diseases. Austin J. Dermatolog. 2014;1:1024.
71. Fowler AJ, Moskowitz DG, Wong A, Cohen SP, Williams ML, Heyman MB. Nutritional status and gastrointestinal structure and function in children with ichthyosis and growth failure. J Pediatr Gastroenterol Nutr. 2004; 38: 164–169.
72. Moskowitz DG, Fowler AJ, Heyman MB, Cohen SP, Crumrine D, Elias PM, Williams ML. Pathophysiologic basis for growth failure in children with ichthyosis: an evaluation of cutaneous ultrastructure, epidermal permeability barrier function, and energy expenditure. J. Pediatr. 2004 Jul;145(1):82–92. DOI: 10.1016/j.jpeds.2004.03.052. PMID: 15238912.
73. Rodríguez-Manchón S, Pedrón-Giner C, Cañedo-Villarroya E, Muñoz-Codoceo RA, Hernández-Martín Á. Malnutrition in children with ichthyosis: Recommendations for monitoring from a multidisciplinary clinic experience. J Am Acad Dermatol. 2021 Jul; 85 (1): 144–151. DOI: 10.1016/j.jaad.2020.06.064. Epub 2020 Jun 22. PMID: 32585277.
74. Prodinger C, Yerlett N, MacDonald C, Chottianchaiwat S, Goh L, Du Toit G, Mellerio JE, Petrof G, Martinez AE. Prevalence of and risk factors for nutritional deficiency and food allergy in a cohort of 21 patients with Netherton syndrome. Pediatr Allergy Immunol. 2023 Jan; 34 (1): e13914. DOI: 10.1111/pai.13914. PMID: 36705039.
75. Kaushik H, Mahajan R, Dabas G, Shrivastava N, Ashraf R, De D, Pal A, Kumar R, Handa S. A cross-sectional study to find association of VDR gene polymorphism with non-syndromic congenital ichthyosis and with vitamin D deficiency. Arch Dermatol Res. 2023 Apr; 315 (3): 551–557. DOI: 10.1007/s00403-022-02399-z. Epub 2022 Oct 3. PMID: 36192561.
Review
For citations:
Mustafaeva D.I. Food allergy and features of nutritional status as a manifestation of epithelial barrier dysfunction in children with congenital ichthyosis. Medical alphabet. 2026;(9):82-88. (In Russ.) https://doi.org/10.33667/2078-5631-2026-9-82-88
JATS XML
























